Clinical studies recruiting near Liverpool

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
NA · Philip Morris Products S.A. · NCT07108166 Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease
Phase 3 · Alder Hey Childrens Hospital · Amgen · NCT04528082 Getting Under the Skin of the Menopausal Hot Flush
Phase N/A · Liverpool John Moores University · Liverpool John Moores University · NCT06222073 Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Phase 3 · Vanda Investigational Site · Vanda Pharmaceuticals · NCT06953869 Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · Galderma Investigational Site 6415 · Galderma R&D · NCT06988605 A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Phase 3 · Site GB44008 · Astellas Pharma Global Development, Inc. · NCT05970172 A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Phase 3 · Alder Hey Children's Hospital · Alfasigma S.p.A. · NCT06865417 Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
Phase 2 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06989359 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Liverpool Hospital · Hoffmann-La Roche · NCT06793215 The Oxford Risk Factors And Non-Invasive Imaging Study
Phase N/A · Liverpool heart and chest hospital · University of Oxford · NCT05169333 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 A Study Assessing HMB-002 in Participants With Von Willebrand Disease
Phase 1/Phase 2 · Royal Liverpool and Broadgreen University Hospitals NHS TRUS · Hemab ApS · NCT06754852 Ultra-Early, Minimally inVAsive intraCerebral Haemorrhage evacUATion Versus Standard trEatment
NA · University of Melbourne · NCT04434807 Adjuvant Tebentafusp in High Risk Ocular Melanoma
Phase 3 · The Clatterbridge cancer Center NHS foundation Trust - Clatt · European Organisation for Research and Treatment of Cancer - · NCT06246149 A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child
Phase 3 · Alder Hey Children's NHS Foundation Trust | Alder Hey Childr · Bayer · NCT07192952 A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Phase N/A · Retina-Vitreous Surgeons of Central NY · Astellas Pharma Global Development, Inc. · NCT06779773 Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer
Phase 2 · Clatterbridge Cancer Centre · Cambridge University Hospitals NHS Foundation Trust · NCT05093231 Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers
NA · Liverpool University Hospitals · University College, London · NCT05604963 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Liverpool Hospital · Regeneron Pharmaceuticals · NCT06091865 ROADMAP Clinical Trial
Phase 4 · Liverpool Hospital · University of Newcastle, Australia · NCT06771050 An Exploratory Physiological Study of Post-operative Recovery in Surgical Neonates and Dimethylarginine:Arginine Levels
Phase N/A · Alder Hey Childrens Hospital NSH Foundation Trust · Liverpool Women's NHS Foundation Trust · NCT06731855 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0055 · Celgene · NCT05519085 Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal
Phase N/A · Clatterbridge Cancer Centre Liverpool · International Extranodal Lymphoma Study Group (IELSG) · NCT05700149 Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003
Phase 1 · Liverpool Hospital, Clinic G-Reception 133, Level 1, Clinica · PYC Therapeutics · NCT06714006 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Aintree University Hospital · Boehringer Ingelheim · NCT06531824 Understanding Inflammation, InFection and Interventions in Severe Exacerbations of Cystic Fibrosis
Phase N/A · Liverpool Heart & Chest Hospital · Alexander Horsley · NCT07484607 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · Liverpool Hospital · Biogen · NCT06962800 SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Phase 2 · Alder Hey Children's NHS Foundation Trust · SAb Biotherapeutics, Inc. · NCT07187531 Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic D
Phase 2 · Site Number - 7003 · Immunovant Sciences GmbH · NCT06979531 A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Phase 3 · Alder Hey Children's Hospital · Eli Lilly and Company · NCT06672549

Look up another city

Look up another condition